472 related articles for article (PubMed ID: 29353703)
21. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
[TBL] [Abstract][Full Text] [Related]
22. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.
Lu X; Wang W; Liu Y; Song N; Li M; Mu X; Zhang N; Chen Q; Jiang L; Kong X; Sun P; Tong J; Zhang Y; Li J; Ma S; Han F
Stem Cell Res; 2022 Apr; 60():102685. PubMed ID: 35093716
[TBL] [Abstract][Full Text] [Related]
24. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
[TBL] [Abstract][Full Text] [Related]
25. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
26. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
Zhang Y; Li A; Huang CL; Wang G; Wang D
Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
[TBL] [Abstract][Full Text] [Related]
27. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
[TBL] [Abstract][Full Text] [Related]
28. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene.
Zhang H; Ma Y; Li X; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
Stem Cell Res; 2019 Dec; 41():101585. PubMed ID: 31775088
[TBL] [Abstract][Full Text] [Related]
29. An integration-free iPSC line (SDQLCHi017-A) derived from a patient with nemaline myopathy-2 disease carrying compound heterozygote mutations in NEB gene.
Ma Y; Zhang H; Li X; Yang X; Li Y; Guan J; Lv Y; Gai Z; Liu Y
Stem Cell Res; 2020 Mar; 43():101729. PubMed ID: 32062132
[TBL] [Abstract][Full Text] [Related]
30. Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene.
Shuvalova LD; Eremeev AV; Bogomazova AN; Novosadova EV; Zerkalenkova EA; Olshanskaya YV; Fedotova EY; Glagoleva ES; Illarioshkin SN; Lebedeva OS; Lagarkova MA
Stem Cell Res; 2020 Apr; 44():101733. PubMed ID: 32151951
[TBL] [Abstract][Full Text] [Related]
31. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
[TBL] [Abstract][Full Text] [Related]
32. Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene.
Rodríguez-Traver E; Rodríguez C; Díaz-Guerra E; Arenas F; Araúzo-Bravo M; Orera M; Kulisevsky J; Moratalla R; Vicario C
Stem Cell Res; 2019 Oct; 40():101578. PubMed ID: 31539859
[TBL] [Abstract][Full Text] [Related]
33. Generation of three human induced pluripotent stem cell (hiPSC) lines derived from one Gaucher disease patient with Parkinson's disease and two unrelated Parkinson's disease patients with GBA mutations.
Tofoli FA; Chien HF; Barbosa ER; Pereira LV
Stem Cell Res; 2019 Aug; 39():101519. PubMed ID: 31401455
[TBL] [Abstract][Full Text] [Related]
34. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
35. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
[TBL] [Abstract][Full Text] [Related]
36. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
37. Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation.
Wang Y; Wei C; Liu Y; Lu X; Wang W; Song N; Zhang W; Xu J; Zhang W; Han F
Stem Cell Res; 2024 Jun; 77():103359. PubMed ID: 38460235
[TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cell line heterozygous for p.R501X mutation in filaggrin: KCLi003-A.
Kolundzic N; Khurana P; Devito L; Jeriha J; Marx J; Hobbs C; Wong XFCC; Common JEA; Liovic M; Dubrac S; Gruber R; Schmuth M; Mauro TM; Ilic D
Stem Cell Res; 2019 Aug; 39():101527. PubMed ID: 31408836
[TBL] [Abstract][Full Text] [Related]
39. Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene.
Ababneh NA; Barham R; Al-Kurdi B; Ali D; Hadidi SA; A Ismail M; Muamar ASH; Abdulelah AA; Madadha A; Sallam M; Hassona Y; Masri A; Awidi A
Stem Cell Res; 2022 Jul; 62():102786. PubMed ID: 35468369
[TBL] [Abstract][Full Text] [Related]
40. Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35.
Larsen SB; Hanss Z; Cruciani G; Massart F; Barbuti PA; Mellick G; Krüger R
Stem Cell Res; 2020 May; 45():101776. PubMed ID: 32387898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
